(Q48643283)

13 February 2018

title

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow (English)

1 reference

13 February 2018

main subject

asenapine

1 reference

ChEBI release 2020-05-28

Olivia Frånberg

1

1 reference

13 February 2018

Monica M Marcus

series ordinal

2

1 reference

13 February 2018

Torgny H Svensson

series ordinal

3

1 reference

13 February 2018

publication date

16 March 2012

1 reference

13 February 2018

published in

Synapse

1 reference

13 February 2018

volume

66

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

650-660

1 reference

13 February 2018

The role of serotonin in the pathophysiology and treatment of schizophrenia

cites work

1 reference

Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex

21 January 2018

1 reference

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

21 January 2018

1 reference

The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity

21 January 2018

1 reference

Serotonin, schizophrenia and antipsychotic drug action

21 January 2018

1 reference

Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex

21 January 2018

1 reference

The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.

21 January 2018

1 reference

Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex

21 January 2018

1 reference

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

21 January 2018

1 reference

Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex

21 January 2018

1 reference

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence

21 January 2018

1 reference

Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms

21 January 2018

1 reference

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.

21 January 2018

1 reference

Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain

21 January 2018

1 reference

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

21 January 2018

1 reference

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

21 January 2018

1 reference

Beneficial effect of the addition of the 5-HT 2A/2C and alpha2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients.

21 January 2018

1 reference

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

21 January 2018

1 reference

Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.

21 January 2018

1 reference

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

21 January 2018

1 reference

Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level

21 January 2018

1 reference

The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex

21 January 2018

1 reference

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

21 January 2018

1 reference

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

21 January 2018

1 reference

Effects of asenapine on prefrontal N‐methyl‐D‐aspartate receptor‐mediated transmission: Involvement of dopamine D1 receptors

21 January 2018

1 reference

Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia

21 January 2018

1 reference

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

21 January 2018

1 reference

Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.

21 January 2018

1 reference

Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission

21 January 2018

1 reference

Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.

21 January 2018

1 reference

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

21 January 2018

1 reference

Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals

21 January 2018

1 reference

Effects of Mianserin on Negative Symptoms in Schizophrenia

21 January 2018

1 reference

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

21 January 2018

1 reference

Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation

21 January 2018

1 reference

Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.

21 January 2018

1 reference

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

21 January 2018

1 reference

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

21 January 2018

1 reference

Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter

21 January 2018

1 reference

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

21 January 2018

1 reference

Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia

21 January 2018

1 reference

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

21 January 2018

1 reference

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

21 January 2018

1 reference

Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

21 January 2018

1 reference

Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality

21 January 2018

1 reference

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

21 January 2018

1 reference

Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia

21 January 2018

1 reference

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

21 January 2018

1 reference

Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence

21 January 2018

1 reference

α2-Adrenoceptor regulates the spontaneous and the GABA/glutamate modulated firing activity of the rat medial prefrontal cortex pyramidal neurons.

21 January 2018

1 reference

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

21 January 2018

1 reference

Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex

21 January 2018

1 reference

D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex.

21 January 2018

1 reference

Proposal for a noradrenaline hypothesis of schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.21551

1 reference

13 February 2018

1 reference

13 February 2018